Abstract
Melatonin has been experimentally implicated in skin functions such as hair growth cycling, fur pigmentation, and melanoma control, and melatonin receptors are expressed in several skin cells including normal and malignant keratinocytes, melanocytes, and fibroblasts. Melatonin is also able to suppress ultraviolet (U)-induced damage to skin cells and shows strong antioxidant activity in Uexposed cells. Moreover, we recently uncovered expression in the skin of the biochemical machinery involved in the sequential transformation of l-tryptophan to serotonin and melatonin. Existence of the biosynthetic pathway was confirmed by detection of the corresponding genes and proteins with actual demonstration of enzymatic activities for tryptophan hydroxylase, serotonin N-acetyl-transferase, and hydroxyindole-O-methyltransferase in extracts from skin and skin cells. Initial evidence for in vivo synthesis of melatonin and its metabolism was obtained in hamster skin organ culture and in one melanoma line. Therefore, we propose that melatonin (synthesized locally or delivered topically)could counteract or buffer external (environmental)or internal stresses to preserve the biological integrity of the organ and to maintain its homeostasis. Furthermore, melatonin could have a role in protection against solar radiation or even in the management of skin diseases.
This is a preview of subscription content, access via your institution.
References
Slominski, A. and Pawelek, J. (1998). Clin. Dermatol. 16, 503–515.
Slominski, A. and Wortsman, J. (2000). Endocr. Rev. 21, 457–487.
Slominski, A., Tobin, D. J., Shibahara, S., and Wortsman, J. (2004). Physiol. Rev. 84, 1155–1228.
Slominski, A. and Wortsman, J. (2003). Minerva Endocrinol. 28, 135–143.
Slominski, A., Wortsman, J., and Tobin, D. J. (2005). FASEB J. 19, 176–194.
Slominski, A., Wortsman, J., Luger, T., Paus, R., and Solomon, S. (2000). Physiol. Rev. 80, 979–1020.
Slominski, A., Wortsman, J., Pisarchik, A., et al. (2001). FASEB J. 15, 1678–1693.
Lerner, A. B., Case, J. D., and Takahashi, Y. (1960). J. Biol. Chem. 235, 1992–1997.
Lerner, A. B., Case, J., and Takahashi, Y. (1958). J. Am. Chem. Soc. 80, 2587.
Yu, H. S. and Reiter, R. J. (1993). Melatonin biosynthesis, physiological effects, and clinical implications, CRC Press, Boca Raton, FL.
Dubocovich, M. L., Rivera-Bermudez, M. A., Gerdin, M. J., and Masana, M. I. (2003). Front. Biosci. 8, d1093-d1108.
Carlberg, C. (2000). Ann. NY Acad. Sci. 917, 387–396.
Reiter, R. J. (2003). Best Pract. Res. Clin. Endocrinol. Metab. 17, 273–285.
Wiesenberg, I., Missbach, M., and Carlberg, C. (1998). Restor. Neurol. Neurosci. 12, 143–150.
Reiter, R. J., Tan, D. X., Manchester, L. C., and El Sawi, M. R. (2002). Ann. NY Acad. Sci. 959, 238–250.
Tan, D. X., Reiter, R. J., Manchester, L. C., et al. (2002). Curr. Top. Med. Chem. 2, 181–197.
Rodriguez, C., Mayo, J. C., Sainz, R. M., et al. (2004). J. Pineal Res. 36, 1–9.
Lerner, A. B. and Case, J. D. (1959). J. Invest. Dermatol. 32, 211–221.
Slominski, A., Pisarchik, A., and Wortsman, J. (2004). Biochim. Biophys. Acta 1680, 67–70.
Slominski, A., Wortsman, J., Plonka, P. M., Schallreuter, K. U., Paus, R., and Tobin, D. J. (2005). J. Invest. Dermatol. 124, 13–21.
Bartsch, C., Bartsch, H., and Karasek, M. (2002). Neuroendocrinol. Lett. 23(Suppl. 1), 30–38.
Gupta, D., Atanasio, A., and Reiter, R. J. (1988). Brain research promotion. Oxford, UK.
Slominski, A., Pisarchik, A., Semak, I., et al. (2002). FASEB J. 16, 896–898.
Slominski, A., Pisarchik, A., Johansson, O., et al. (2003). Biochim. Biophys. Acta 1639, 80–86.
Slominski, A., Pisarchik, A., Semak, I., Sweatman, T., and Wortsman, J. (2003). Eur. J. Biochem. 270, 3335–3344.
Semak, I., Korik, E., Naumova, M., Wortsman, J., and Slominski, A. (2004). Arch. Biochem. Biophys. 421, 61–66.
Slominski, A., Pisarchik, A., Semak, I., Sweatman, T., Szczesniewski, A., and Wortsman, J. (2002). J. Invest. Dermatol. 119, 934–942.
Slominski, A., Semak, I., Pisarchik, A., Sweatman, T., Szczesniewski, A., and Worstman, J. (2002). FEBS Lett. 511, 102–106.
Gillbro, J. M., Marles, L. K., Hibberts, N. A., and Schallreuter, K. U. (2004). J. Invest. Dermatol. 123, 346–353.
Schallreuter, K. U., Lemke, K. R., Pittelkow, M. R., Wood, J. M., Korner, C., and Malik, R. (1995). J. Invest. Derm. 104, 953–957.
Schallreuter, K. U., Schulz-Douglas, V., Bunz, A., Beazley, W. D., and Korner, C. (1997). J. Invest. Dermatol. 109, 31–35.
Coon, S. L., Roseboom, P. H., Baler, R., et al. (1995). Science 270, 1681–1683.
Roseboom, P. H., Namboodiri, M. A., Zimonjic, D. B., et al. (1998). Brain Res. Mol. Brain Res. 63, 189–197.
Conti, A., Conconi, S., Hertens, E., et al. (2000). J. Pineal Res. 28, 193–202.
Slominski, A., Baker, J., Rosano, T., et al. (1996). J. Biol. Chem. 271, 12281–12286.
Cahill, G. M. and Besharse, J. C. (1989). Proc. Natl. Acad. Sci. USA 86, 1098–1102.
Grace, M. S., Cahill, G. M., and Besharse, J. C. (1991). Brain Res. 559, 56–63.
Becker-Andre, M., Wiesenberg, I., Schaeren-Wiemers, N., et al. (1994). J. Biol. Chem. 269, 28531–28534.
Carlberg, C., Hooft van Huijsduijnen, R., Staple, J. K., DeLamarter, J. F., and Becker-Andre, M. (1994). Mol. Endocrinol. 8, 757–770.
Nosjean, O., Nicolas, J. P., Klupsch, F., Delagrange, P., Canet, E., and Boutin, J. A. (2001). Biochem. Pharmacol. 61, 1369–1379.
Nosjean, O., Ferro, M., Coge, F., et al. (2000). J. Biol. Chem. 275, 31311–31317.
Slominski, A., Pisarchik, A., Zbytek, B., Tobin, D. J., Kauser, S., and Wortsman, J. (2003). J. Cell Physiol. 196, 144–153.
Slominski, A., Pisarchik, A., Tobin, D. J., Mazurkiewicz, J. E., and Wortsman, J. (2004). Endocrinology 145, 941–950.
Pisarchik, A. and Slominski, A. (2004). Eur. J. Biochem. 271, 2821–2830.
Pozo, D., Garcia-Maurino, S., Guerrero, J. M., and Calvo, J. R. (2004). J. Pineal Res. 37, 48–54.
Becker-Andre, M., Andre, E., and DeLamarter, J. F. (1993). Biochem. Biophys. Res. Commun. 194, 1371–1379.
Carrillo-Vico, A., Garcia-Perganeda, A., Naji, L., Calvo, J. R., Romero, M. P., and Guerrero, J. M. (2003). Cell Mol. Life Sci. 60, 2272–2278.
Mailliet, F., Ferry, G., Vella, F., Thiam, K., Delagrange, P., and Boutin, J. A. (2004). FEBS Lett. 578, 116–120.
Strassburg, A., Strassburg, C. P., Manns, M. P., and Tukey, R. H. (2002). Mol. Pharmacol. 61, 320–325.
Buryanovskyy, L., Fu, Y., Boyd, M., et al. (2004). Biochemistry 43, 11417–11426.
Welch, R. A. S., Gurnsey, M. P., Betteridge, K., and Mitchell, R. J. (1990). Proc. N. Z. Soc. Anim. Prod. 50, 335–338.
Nixon, A. J., Choy, V. J., Parry, A. L., and Pearson, A. J. (1993). J. Exp. Zool. 267, 47–56.
Ibraheem, M., Galbraith, H., Scaife, J., and Ewen, S. (1994). J. Anat. 185(Pt. 1), 135–142.
Slominski, A., Chassalevris, N., Mazurkiewicz, J., Maurer, M., and Paus, R. (1994). Exp. Dermatol. 3, 45–50.
Kobayashi, H. and Paus, R. (2005). Exp. Dermatol. 14, 157.
Fischer, T. W., Fischer, A., Knöll, B., Hipler, U. C., and Elsner, P. (2000). Arch. Derm. Res. 292, 147.
Fischer, T. W., Burmeister, G., Schmidt, H. W., and Elsner, P. (2004). Br. J. Dermatol. 150, 341–345.
Fischer, T., Wigger-Alberti, W., and Elsner, P. (1999). Hautarzt 50, 5–11.
Drobnik, J. and Dabrowski, R. (1999). Cytobios. 100, 49–55.
Drobnik, J. and Dabrowski, R. (1996). Cytobios. 85, 51–58.
Pertsov, S. S., Abramov, Y. V., Volodina, T. V., and Rebrov, L. B. (2004). Bull. Exp. Biol. Med. 137, 327–330.
Soybir, G., Topuzlu, C., Odabas, O., Dolay, K., Bilir, A., and Koksoy, F. (2003). Surg. Today 33, 896–901.
Fischer, T. W. and Elsner, P. (2001). Curr. Probl. Dermatol. 29, 165–174.
Bangha, E., Elsner, P., and Kistler, G. S. (1996). Arch. Dermatol. Res. 288, 522–526.
Bangha, E., Elsner, P., and Kistler, G. S. (1997). Dermatology 195, 248–252.
Dreher, F., Denig, N., Gabard, B., Schwindt, D. A., and Maibach, H. I. (1999). Dermatology 198, 52–55.
Dreher, F., Gabard, B., Schwindt, D. A., and Maibach, H. I. (1998). Br. J. Dermatol. 139, 332–339.
Lee, K. S., Lee, W. S., Suh, S. I., et al. (2003). Exp. Mol. Med. 35, 263–268.
Ryoo, Y. W., Suh, S. I., Mun, K. C., Kim, B. C., and Lee, K. S. (2001). J. Dermatol. Sci. 27, 162–169.
Fischer, T. W., Scholz, G., Knoll, B., Hipler, U. C., and Elsner, P. (2001). J. Pineal Res. 31, 39–45.
Fischer, T. W., Scholz, G., Knoll, B., Hipler, U. C., and Elsner, P. (2004). J. Pineal Res. 37, 107–112.
Fischer, T. W., Scholz, G., Knoll, B., Hipler, U. C., and Elsner, P. (2002). Skin Pharmacol. Appl. Skin Physiol. 15, 367–373.
Pisarchik, A., Wortsman, J., and Slominski, A. (2004). Gene 341, 199–207.
Maharaj, D. S., Anoopkumar-Dukie, S., Glass, B. D., et al. (2002). J. Pineal Res. 32, 257–261.
Kanikkannan, N., Jackson, T., Shaik, M. S., and Singh, M. (2001). Eur. J. Pharm. Sci. 14, 217–220.
Hussein, M. R., Abu-Dief, E. E., Abd El-Reheem, M. H., and Abd-Elrahman, A. (2005). Int. J. Exp. Pathol. 86, 45–55.
Sener, G., Atasoy, B. M., Ersoy, Y., Arbak, S., Sengoz, M., and Yegen, B. C. (2004). J. Pineal Res. 37, 241–246.
Vasin, M. V., Ushakov, I. B., Kovtun, V., Komarova, S. N., Semenova, L. A., and Galkin, A. A. (2004). Radiat. Biol. Radioecol. 44, 68–71.
Kim, B. C., Shon, B. S., Ryoo, Y. W., Kim, S. P., and Lee, K. S. (2001). J. Dermatol. Sci. 26, 194–200.
Kilanczyk, E. and Bryszewska, M. (2003). Cell. Mol. Biol. Lett. 8, 333–336.
Gurlek, A., Aydogan, H., Parlakpinar, H., et al. (2004). J. Pineal Res. 36, 58–63.
Tunali, T., Sener, G., Yarat, A., and Emekli, N. (2005). Life Sci. 76, 1259–1265.
Basak, P. Y., Agalar, F., Gultekin, F., Eroglu, E., Altuntas, I., and Agalar, C. (2003). Ulus. Travma. Derg. 9, 96–101.
Karbownik, M. (2002). Neuroendocrinol. Lett. 23(Suppl. 1), 39–44.
Kumar, C. A. and Das, U. N. (2000). Med. Sci. Monit. 6, 471–475.
Bangha, E., Lauth, D., Kistler, G. S., and Elsner, P. (1997). Skin Pharmacol. 10, 298–302.
Fischer, T. W., Greif, C., Fluhr, J. W., Wigger-Alberti, W., and Elsner, P. (2004). Skin Pharmacol. Physiol. 17, 190–194.
Oh, H. J., Oh, Y. K., and Kim, C. K. (2001). Int. J. Pharm. 212, 63–71.
Cos, S. and Sanchez-Barcelo, E. J. (2000). Front. Neuroendocrinol. 21, 133–170.
Gonzalez, R., Sanchez, A., Ferguson, J. A., et al. (1990). Melanoma Res. 1, 237–243.
Lissoni, P., Malugani, F., Malysheva, O., et al. (2002). Neuroendocrinol. Lett. 23, 341–344.
Lissoni, P., Vaghi, M., Ardizzoia, A., et al. (2002). In Vivo 16, 93–96.
Reiter, R. J., Tan, D. X., Sainz, R. M., Mayo, J. C., and Lopez-Burillo, S. (2002). J. Pharm. Pharmacol. 54, 1299–1321.
Pisarchik, A. and Slominski, A. T. (2001). FASEB J. 15, 2754–2756.
Fischer, T. W., Zbytek, B., Sayre, R. M., et al. (2005). J. Pineal Res., in press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slominski, A., Fischer, T.W., Zmijewski, M.A. et al. On the role of melatonin in skin physiology and pathology. Endocr 27, 137–147 (2005). https://doi.org/10.1385/ENDO:27:2:137
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:27:2:137
Key Words
- Skin
- melatonin
- serotonin
- N-acetylserotonin
- ultraviolet radiation